Clinical Trial to Evaluate AB011 Injection in Patients With CLDN18.2-positive Advanced Solid Tumors

NCT04400383 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor
Gastric Cancer
Pancreatic Adenocarcinoma

Interventions

DRUG: AB011 Injection

Sponsor

CARsgen Therapeutics Co., Ltd.

Collaborators

[object Object]